About CELLINK
CELLINK is a company based in Boston (United States) founded in 2016.. CELLINK has completed 8 acquisitions, including Cytena, Dispendix and Echo Laboratories. CELLINK operates in a competitive market with competitors including Nuclera Nucleics, Aspect Biosystems, Collplant, ROKIT Healthcare and Triastek, among others.
- Headquarter Boston, United States
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$323.15 M (USD), Post-IPO
Mar 11, 2021
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Cytena
& 7 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Sales and Marketing
10 people
Software Development Team
5 people
Human Resources and Administration
4 people
Finance and Accounting
4 people
Product Management Team
3 people
Senior Team
2 people
Leadership Team
2 people
Global Team
1 people
Unlock access to complete
Funding Insights of CELLINK
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $323.1M
-
First Round
First Round
(01 Oct 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2021 | Amount | Post-IPO - CELLINK | Valuation |
investors |
|
| Jan, 2021 | Amount | Grant - CELLINK | Valuation |
investors |
|
| Sep, 2020 | Amount | Grant - CELLINK | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CELLINK
CELLINK has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CELLINK
CELLINK has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Cytena, Dispendix and Echo Laboratories. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Non-contact nanoliter dispensing technology is developed and offered.
|
2015 | ||||
|
Single cells are isolated using the cy-Clone device technology.
|
2014 | ||||
|
Hybrid optical microscope
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - CELLINK
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellink Comparisons
Competitors of CELLINK
CELLINK operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, Aspect Biosystems, Collplant, ROKIT Healthcare and Triastek, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
4D bio-printer solutions for tissue regeneration are provided.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing pharmaceutical technology platform for drug design
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cellink
Frequently Asked Questions about CELLINK
When was CELLINK founded?
CELLINK was founded in 2016.
Where is CELLINK located?
CELLINK is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
What does CELLINK do?
CELLINK was founded in 2016 in Boston, United States, within the biotechnology sector. 3D bioprinters are designed and developed for applications in cell culture, tissue engineering, and drug development. Bioinks, single-cell dispensers, liquid handlers, bioreactors, live-cell analyzers, omics tools, NGS reagents, biomaterials, and various consumables are also provided to support research operations.
Who are the top competitors of CELLINK?
CELLINK's top competitors include Nuclera Nucleics, Aspect Biosystems and Allevi.
How many acquisitions has CELLINK made?
CELLINK has made 8 acquisitions, including Cytena, Dispendix, and Echo Laboratories.
Who are CELLINK's investors?
CELLINK has 1 investor. Key investors include European Union.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.